Stay updated on CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page.

Latest updates to the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page
- Check2 days agoChange DetectedA MedlinePlus Genetics link related to schizophrenia appears in the study’s resource links, and the site revision changes from v3.8.0 to v3.8.1.SummaryDifference0.2%

- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the completed Phase 2 CTP-692 schizophrenia study is displayed, including its design, participant criteria, study locations, and measured outcomes. Study documents and record history are also available.SummaryDifference55%

- Check16 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record page now displays a 403 Forbidden error with a Home button, indicating the record is currently inaccessible. This reflects a site access issue rather than an actual update to the study data.SummaryDifference17%

Stay in the know with updates to CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page.